Summary of Key Information:
Reporting Period (Quarter/Year): Not Applicable
Nature of Filing / Announcement: Outcome of Board Meeting - ESOP Allotment and New Grant
Audit Opinion:
Not Specified
Key Financial Highlights:
Not Specified
Standalone Results:
Not Specified
Consolidated Results:
Not Specified
Segment-wise Performance:
Not Specified
Corporate Actions:
- Allotment of 3,420 equity shares of ₹10 each to eligible employee upon exercise of vested options under Entero Employee Stock Option Plan 2023
- Fresh grant of 17,500 Employee Stock Options under existing "Entero Employee Stock Option Plan 2023"
- Exercise price: ₹804 per equity share
- Premium per share: ₹794
- Total issued shares after allotment: 4,35,21,597
- Total issued share capital after allotment: ₹43,52,15,970
- Distinctive share numbers: 4,35,18,178 to 4,35,21,597
- Shares issued are freely transferable with no lock-in period restrictions
Other Significant Information:
- Previous filing dates for ESOP statement: BSE: 20/09/2024 (Filing No: 212075), NSE: 20/09/2024 (Filing No: 44198)
- Information available on company website: www.enterohealthcare.com